Travere Therapeutics is a biotechnology company that develops treatments for rare diseases. The company's products are focused on the treatment of kidney diseases, including focal segmental glomerulosclerosis (FSGS) and Alport syndrome. Travere Therapeutics was founded in 1998 and is headquartered in Alameda, California.